The kidney failure risk equation (KFRE) has been shown to accurately estimate progression to kidney failure in adults with chronic kidney disease (CKD). Use of the KFRE in children with CKD, if accurate, would help to optimize planning for end-stage renal disease (ESRD) care.
T he kidney failure risk equations (KFREs) were originally developed in a large Canadian cohort to aid in clinical decision making for adults with chronic kidney disease (CKD). 1 These equations have been shown to be highly accurate in the identification of adults at high risk for progression to end-stage renal disease (ESRD) and can be used to help optimize the timing of dialysis access and/or kidney transplant. Since their development, these risk equations have been validated in diverse adult populations worldwide. [2] [3] [4] Although risk factors for disease progression in children with CKD have been well-established, 5 no established risk equations currently help to determine when a child will likely require renal replacement therapy. Improved estimation of when a child with CKD will experience progression to ESRD has several potentially valuable applications. First, knowledge of the risk of ESRD within a specified period would improve the ability of clinicians to give anticipatory guidance to patients and their families. Second, routine use of the KFRE may improve rates of preemptive kidney transplant (transplant before the need for dialysis occurs). Preemptive transplant currently occurs in only 22% of children with ESRD despite increasing evidence in children with CKD that preemptive transplant improves allograft and patient survival [6] [7] [8] [9] and that prompt transplant confers additional benefits, including improved health-related quality of life, cognition, and growth in children, compared with maintenance dialysis. [10] [11] [12] [13] Third, better estimation of the timing of ESRD onset would allow for improved completion of immunizations in children with CKD before transplant, which is currently suboptimal despite the significant morbidity and mortality associated with vaccine-preventable infections after transplant. 14, 15 In addition, in rural areas with no ready access to pediatric nephrologists, 16 improved estimation of when a child will progress to ESRD might aid general practitioners in timing referrals to nephrology. The objective of this study was to apply the KFREs to a pediatric CKD cohort to determine whether these equations accurately discriminate the risk of ESRD in children.
Methods

Study Population
We studied participants enrolled in the Chronic Kidney Disease in Children (CKiD) study. 17 Details of the CKiD study design have been published previously. 18, 19 In brief, the CKiD study enrolled children and adolescents aged 1 to 16 years (hereinafter referred to as children) with an estimated glomerular filtration rate (eGFR) from 30 to 90 mL/min/1.73 m 2 and followed them up prospectively from January 1, 2005, through July 31, 2013. For the purpose of this study, we included all children in the CKiD study with an eGFR of less than 60 mL/min/1.73 m 2 using the bedside Schwartz equation 20 at baseline enrollment. We chose to include only children with an eGFR of less than 60 mL/min/1.73 m 2 , because the KFRE was developed and validated in adults with an eGFR below this level. For participants who did not have an eGFR of less than 60 mL/min/1.73 m 2 at the time of baseline enrollment into the CKiD study, the first visit when the eGFR fell below 60 mL/min/1.73 m 2 was used as their baseline visit.
Participants with missing covariates needed for determination of the KFRE were excluded. Participants were also excluded if they had a diagnosis of hyperoxaluria, because these participants may start renal replacement at higher levels of renal function than the norm. The institutional review board of the University of California considered this study exempt from research approval for human subjects. Informed consent was obtained locally from study participants at all CKiD sites.
Variables
The primary predictive factor was the calculated risk of kidney failure (percentage of risk of developing ESRD within a 1-, 2-, or 5-year period). The 4-variable (age, sex, eGFR, and ratio of albumin to creatinine levels [ACR]) and the 8-variable (4 variables plus serum calcium, phosphate, bicarbonate, and albumin levels) KFREs were used as primary predictive factors in separate models. 1, 3, 4 The variables needed to determine the risk, as described above, were obtained from the baseline visit or the visit when eGFR first decreased to below 60 mL/min/1.73 m 2 . Because albuminuria was not uniformly measured in the CKiD study, the ratio of protein to creatinine levels (PCR) was transformed to an ACR using a published equation. 3 We ascertained the adequacy of this conversion by determining the correlation between the ACR and the PCR transformed to ACR (Spearman r = 0.9; P < .001).
The study outcome of interest was time to ESRD, defined as receipt of long-term dialysis or kidney transplant (whichever came first). Additional covariates of interest included sex, race, ethnicity, cause of CKD, systolic and diastolic blood pressure measurements, and hemoglobin level.
Statistical Analysis
Data were analyzed from September 30, 2016, through September 8, 2017. For our analysis, Cox proportional hazards models were used to examine the association between estimated risk of kidney failure and time to ESRD. Postestimation C statistics were used to determine the ability of the KFRE to discriminate the risk of ESRD. Confidence intervals for the C statistics and their difference were determined using a bootstrap approach with 500 repetitions. We also examined whether discrimination of the KFRE was different among the following prespecified subgroups: age (≥12 vs <12 years), sex, race (white vs nonwhite), ethnicity (Hispanic vs non-Hispanic), and cause of
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Findings In this cohort study of 603 children with chronic kidney disease in the Chronic Kidney Disease in Children study, the kidney failure risk equation score was associated with progression to end-stage renal disease at 1, 2, and 5 years.
Meaning Use of the kidney failure risk equation in children with chronic kidney disease may improve the ability to determine the short-and intermediate-term risk for progression to end-stage renal disease; this knowledge may improve the timing of appropriate anticipatory guidance and preparation for kidney transplant or dialysis.
CKD (glomerular vs nonglomerular)
. Participants who died (n = 2) were censored from our analysis at the time of death; therefore, deaths were not treated as a competing risk given their rare occurrence within this pediatric cohort.
In secondary analyses to determine whether the model was well-calibrated, we divided the cohort into risk tertiles based on the 2-year, 8-variable KFRE scores, and we fit KaplanMeier survival curves to each risk tertile to determine whether the estimated survival matched the actual survival. In addition, we compared characteristics of participants with a KFRE score of greater than 13% (representing the highest tertile) at 2 years with those with a KFRE risk score of 13% or less at 2 years using the unpaired 2-tailed t test, χ 2 test, or Wilcoxon rank sum test as appropriate.
Sensitivity Analyses
To determine whether the ACR derived from mathematical conversion would yield results similar to actual ACR measurements, we compared risk discrimination by the 2-year, 8-variable KFRE among the subset of the population that had measured and calculated ACR data available. All data were derived from the National Institute of Diabetes and Digestive and Kidney Diseases Central Repository in deidentified form, and data were administratively censored as of July 2013. Dates of birth in this data set were rounded to the nearest year to protect patient identity. All data analyses were conducted using STATA software (version 13; StataCorp).
Results
A total of 603 participants (378 boys [62.7%] and 225 girls [37.3%]; median age at study entry, 12 years; interquartile range [IQR], 8-15 years) met our inclusion criteria and were included for study. We identified 636 children in the cohort with an eGFR of less than 60 mL/min/1.73 m 2 , of whom 31 were missing data necessary for the KFRE calculations, and 2 additional participants were excluded for a diagnosis of hyperoxaluria. Of the 603 children remaining, 528 had an eGFR of less than 60 mL/min/1.73 m 2 at baseline enrollment into the CKiD, and an additional 75 children were included at the time when their eGFR decreased to less than 60 mL/min/1.73 m 2 at a CKiD follow-up visit.
Demographic, baseline physical examination, and laboratory data are shown in ). Four hundred one participants (66.5%) were white, 506 (83.9%) were non-Hispanic, and 457 (75.8%) had a nonglomerular cause of CKD. During the follow-up period, 27 (4.5%) progressed to ESRD by 1 year of follow-up; 62 (10.3%), by 2 years; and 144 (23.9%), by 5 years. The median follow-up time for the cohort was 3.8 years (IQR, 1.7-6.2 years). 
Research Original Investigation
The results of the application of the KFRE to our cohort are shown in Table 2 . Overall, the equation provided excellent discrimination and was similar whether the 4-or 8-variable equation was used. As shown in Figure 1 , although performance of the KFRE was similar by race and cause of CKD, a statistically significant difference occurred in discriminatory performance by ethnicity and age. The Results from our model calibration are shown in Figure 2 . The cohort was divided into risk group tertiles based on the 2-year, 8-variable KFRE score as follows: estimated risk group 1 corresponds to a 2-year KFRE score of less than 2.6%; estimated risk group 2, a KFRE score of at least 2.6% but less than 13.2%; and estimated risk group 3, a KFRE score of at least 13.2%. The median KFRE score for those in the highest tertile was 33%. As depicted in Figure 2 , the estimated proportion of participants who developed ESRD closely matched the observed proportion who progressed to ESRD at 2 years.
We compared the characteristics of children with a 2-year KFRE score in the top tertile (>13%) with those of children in the lower tertiles (≤13%) ( Table 3) . Overall, the median 2-year KFRE score was 6% (IQR, 2%-21%). Of the entire cohort, 202 children (33.5%) had a 2-year KFRE score of greater than 13%, and 55 (27.2%) of this group progressed to ESRD within 2 years of follow-up compared with only 7 of 401 (1.7%) with a 2-year KFRE score of 13% or less. Participants with a 2-year KFRE score above 13% were notably older and more often male and had higher blood pressures and lower hemoglobin levels at the time of entry into our study.
One hundred forty-six participants (24.2%) had measured ACR data available. For this subset of patients, no difference was found in the 2-year risk discrimination using the KFRE (C statistic, 0.96 for models including measured or calculated ACR; 95% CI for the difference in C statistics, −0.001 to 0.30).
Discussion
Few tools are currently available to estimate whether a child with CKD will develop ESRD within 5 years. In this study, we used a validated risk equation originally developed in an adult cohort to determine whether equal risk discrimination could be provided with the use of the KFRE in children. Overall, we found that the KFRE score provides excellent discrimination and calibration of the risk of ESRD in a pediatric cohort with stages 3 and 4 CKD. The KFRE is a simple tool that uses routinely collected demographic and laboratory data and can easily be applied by all clinicians caring for children with CKD to help provide anticipatory guidance, gauge timing of referral to subspecialty care and transplant centers, and plan for the optimal timing of dialysis access and kidney transplant. assessed the accuracy of the KFREs for estimating the risk of kidney failure using the CKD Prognosis Consortium with participants from 30 countries and generally found that the equations remained highly accurate, although a calibration factor was suggested for non-North American cohorts for which the original equation overestimated risk. Our study is novel in the application of this risk equation for the first time, to our knowledge, to a large cohort of children with CKD.
Although an equation developed in adults who have different causes of their CKD performed well in children, the variables used in the KFRE notably include those that have been previously identified as risk factors for CKD progression in adults and children.
5 Warady et al 5 previously found that older age, male sex, proteinuria, hypoalbuminemia, and hyperphosphatemia were associated with a shorter time to CKD progression in children with a nonglomerular cause of ESRD, although for those with a glomerular cause, age, sex, and hyperphosphatemia were not associated with ESRD risk. For all causes of CKD, additional risk factors not accounted for in the KFRE but previously identified as being important in children included elevated blood pressure and anemia. 5 In contrast to what would be expected based on the previously cited study, a glomerular vs nonglomerular cause of CKD did not significantly affect performance of the KFRE, although the number of patients with glomerular causes of CKD was lower in the CKiD cohort. 5 In addition, those with glomerular causes of CKD would be expected to have more albuminuria, 21 which is likely the main driver of CKD progression in this population, as evidenced by the high C statistic with use of the KFRE even among this subpopulation. We found better performance of the KFRE in younger children and those of Hispanic ethnicity. The reasons for differences by age are unclear, although we speculate that in younger children, kidney disease tends to have nonglomerular causes (congenital anomalies of the kidney and urinary tract) and therefore may have a more predictable pattern of progression. In addition, progression of CKD in older children may be subject to additional confounders, including nonadherence to therapy 22 and increased heterogeneity in the causes of CKD, which may decrease the KFRE's ability to discriminate the risk of ESRD. We believe that the difference in performance of the KFRE by ethnicity deserves further exploration and validation, and we cannot definitively rule out the possibility that this finding occurred by chance. We did not, on the other hand, find statistically significant differences in performance of the KFRE by race or cause of CKD.
Use of the KFRE may provide opportunities to improve the care of children with CKD. The provision of better tools to estimate the timing of ESRD onset could allow for better timing of living donor workup and planning for preemptive transplant. Preemptive transplant is associated with better renal allograft and patient survival among children compared with any dialysis exposure 9 thus, the KFRE score would be useful in appropriately timing referral to pediatric dialysis and transplant centers for endstage care. This use is especially important given that late referral to pediatric nephrology care has been associated with a decreased likelihood of preemptive transplant. 23 Vaccination rates before kidney transplant may also be improved 15 with better estimation of the amount of time before ESRD onset. Specifically, an accelerated vaccine schedule might be appropriate for the child rapidly progressing to ESRD, and revaccination for children without protective antibody titers should be strongly considered before kidney transplant, after which live vaccines are contraindicated. 14 In addition, all clinicians could use the information gained from use of the KFRE to provide counseling and guide families in the planning of important life decisions regarding finances, housing, and education. However, we would emphasize that a low 5-year KFRE score does not mean that the lifetime risk of ESRD is necessarily low. Given the long-term survival of most pediatric patients with CKD, the lifetime risk of kidney failure may still be significant, and ongoing interventions that retard the progression of CKD should still be aggressively pursued.
Strengths and Limitations
Our study has several strengths and limitations. Our study is strengthened by the relatively large size of this pediatric CKD cohort with national representation and comprehensive follow-up data, including ascertainment of time to ESRD. Our study is limited by missing albuminuria measurements, although we were able to estimate albuminuria from proteinuria measurements using a previously validated approach with high correlation. 3 Our study is also limited by the median follow-up time of only 3.8 years, which may explain the relatively lower C statistic for the 5-year KFRE score compared with shorter-term risk scores in this cohort. Our study results may not be generalizable to the larger population of children with CKD, given that enrollment in the CKiD study is voluntary and therefore may select for more adherent patients and families.
